The Kidney Health Initiative

The Kidney Health Initiative (KHI) is a partnership between the U.S. Food and Drug Administration (FDA) and the kidney community, including patients, healthcare professionals, and researchers. Its goal is to improve kidney disease treatment and research by developing better drug and device safety standards, fostering innovation, and advancing knowledge about kidney health. KHI facilitates collaboration to address challenges in diagnosing, managing, and preventing kidney conditions, ultimately aiming to enhance patient outcomes and quality of life through scientific progress and regulatory support.